On Tuesday, Following Stocks were among the “Top Gainers” of U.S. Stock Market: Great Basin Scientific, (NASDAQ:GBSN), Nymox Pharmaceutical, (NASDAQ:NYMX), RADA Electronic Industries, (NASDAQ:RADA), E-Commerce China Dangdang, (NYSE:DANG)
Great Basin Scientific, (NASDAQ:GBSN), with shares skyrocketed 59.84%, closed at $3.90.
Nymox Pharmaceutical, (NASDAQ:NYMX), with shares jumped 27.27%, settled at $0.84.
RADA Electronic Industries, (NASDAQ:RADA), with shares climbed 11.97%, and closed at $2.90.
E-Commerce China Dangdang, (NYSE:DANG), surged 13.96%, and closed at $9.55.
Latest NEWS regarding these Stocks are depicted underneath:
Great Basin Scientific, Inc. (NASDAQ:GBSN)
Great Basin Scientific, Inc. (GBSN), declared that the United States Patent and Trademark Office (USPTO) issued a notice of allowance for patent 8,936,921 for the Corporation’s method of isothermal helicase-dependent amplification (HDA) using blocked primers (bp), or “bpHDA.” bpHDA creates a highly specific “hot-start” functionality which raises the amplification speed, improves assay sensitivity and expands multiplex capabilities of Great Basin’s sample-to-result molecular diagnostic testing technology. bpHDA is the basis of the Corporation’s Clostridium difficile (C. diff) molecular diagnostic test assay.
“We believe that with these patents, Great Basin offers a platform for molecular diagnostics unlike any presently accessible system,” said Ryan Ashton, co-founder and Chief Executive Officer of Great Basin. “Using one system, our technology is capable of answering both the ‘What is it?’ question, answered by a low-cost, low-plex assay, and the ‘What is causing it?’ question, identified by a multi-plex panel. We contend this will allow hospital labs to invest in fewer systems while providing more answers with an easy-to-use and cost effective system.”
Great Basin Scientific, Inc., a molecular diagnostic testing corporation, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-attained infections.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
Nymox Pharmaceutical Corporation (NYMX), declared its financial results for the year ended December 31, 2014 prepared in accordance with International Financial Reporting Standards. Nymox stated a net loss of $4,594,093, or $0.13 per share for the year ended December 31, 2014, contrast to $4,908,603, or $0.14 per share for same period in 2013. The decrease of the net loss for the year is attributable primarily to a reduction of $1,696,384 in clinical trial expenditures related to NX-1207 studies offset by an raise of $1,272,588 in stock compensation charges. The weighted average number of ordinary shares outstanding for the year ended December 31, 2014 was 35,253,879, contrast to 34,147,666 for the same period in 2013.
Proceeds from sales amounted to $331,909 for the year ended December 31, 2014, contrast to $741,410 for the same period in 2013. The decrease in 2014 contrast to the same period in 2013 is due to the non-recurrence of the sale of goods of $333,249 in 2013 under our licensing contract with Recordati in addition to a decrease in sales of NicAlert(TM)/TobacAlert(TM). Additionally, an amount of $2,617,600 was recognized as proceed in both 2014 and 2013 regarding the upfront payment received following our licensing contract with Recordati in December 2010.
Nymox Pharmaceutical Corporation, a biopharmaceutical corporation, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to tobacco products, in addition to AlzheimAlert, a proprietary urine assay that aid physicians in the diagnosis of Alzheimer’s disease.
RADA Electronic Industries Ltd. (NASDAQ:RADA)
RADA Electronic Industries Ltd. (RADA), declared that it has signed a planned teaming contract with DRS Technologies, Inc. to bring RADA’s tactical active electronically scanned array (AESA) radar technology into the North American market.
Under this contract, DRS will market, sell, produce and support tactical AESA radars as part of its tactical radar portfolio. The combination of RADA’s technology together with DRS market presence, customer awareness, engineering, and production capabilities is predictable to produce noteworthy interest in the North American defense industry market.
RADA Electronic Industries Ltd., a defense electronics contractor, is engaged in the development, manufacture, and sale of defense electronics to various air forces and companies worldwide.
E-Commerce China Dangdang Inc. (NYSE:DANG)
E-Commerce China Dangdang Inc. (DANG), declared its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2014.
Dangdang’s total net proceeds in the fourth quarter of 2014 were RMB2,505.0 million ($403.7 million), a 27.0% raise from the corresponding period in 2013.
Dangdang had about 9.8 million active customers, counting about 3.7 million new customers, in the fourth quarter of 2014, representing raises of 10% and 20%, respectively, from the corresponding period in 2013. Total orders for the fourth quarter of 2014 were about 20.4 million, a 13% raise from the corresponding period in 2013.
Gross margin in the fourth quarter of 2014 was 17.1%, contrast to 17.6% in the fourth quarter of 2013 and 18.9% in the third quarter of 2014. The year-over-year and quarter-over-quarter decreases in gross margin were due to a larger contribution of general merchandise sales as a percentage of total net proceeds and a decline in shipping proceed from third-party merchants.
Dangdang recorded operating revenue of RMB22.5 million ($3.6 million) in the fourth quarter of 2014, representing a 217.0% raise from RMB7.1 million in the corresponding period in 2013.
Net revenue was RMB32.8 million ($5.3 million), representing a 51.4% raise from RMB21.7 million in the corresponding period in 2013.
Diluted earnings per ADS was RMB0.39 ($0.06), contrast to RMB0.26 in the corresponding period in 2013.
Capital expenditures for the fourth quarter of 2014 were RMB26.7 million ($4.3 million).
E-Commerce China Dangdang Inc. operates as a business-to-consumer e-commerce corporation in the People’s Republic of China. It primarily sells books, audio-visual products, periodicals, consumer electronics, and electronic publications through its Website dangdang.com.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
